AIIMS Guwahati Launches Clinical Trial Unit to Boost Research

- Advertisement -
- Advertisement -

HT Digital,

Guwahati, 16 Oct: All India Institute of Medical Sciences (AIIMS) Guwahati inaugurated its Clinical Trial Unit (CTU) on Wednesday, aiming to strengthen clinical research in the North East. The unit is designed to support high-quality, ethical, and patient-centred studies, providing infrastructure and expertise for both investigator-initiated and sponsor-led trials.

- Advertisement -

Prof Dr Ashok Puranik, Executive Director of AIIMS Guwahati, said the CTU will translate scientific research into improved health outcomes. He highlighted that the unit will enhance patient access to advanced therapies, address regional and national health priorities, and foster the development of research talent across the region.

The CTU is expected to promote collaborations with national networks and international partners, positioning AIIMS Guwahati as a hub for healthcare innovation in the North East. Through these partnerships, the institute aims to focus on diseases of regional significance and strengthen public health interventions across the country.

- Advertisement -
The Hills Times
The Hills Timeshttps://www.thehillstimes.in/
Welcome to The Hills Times, your trusted source for daily news and updates in English from the heart of Assam, India. Since our establishment in 2000, we've been dedicated to providing timely and accurate information to our readers in Diphu and Guwahati. As the first English newspaper in the then undemarcated Karbi Anglong district, we've forged a strong connection with diverse communities and age groups, earning a reputation for being a reliable source of news and insights. In addition to our print edition, we keep pace with the digital age through our website, https://thehillstimes.in, where we diligently update our readers with the latest happenings day by day. Whether it's local events, regional developments, or global news, The Hills Times strives to keep you informed with dedication and integrity. Join us in staying ahead of the curve and exploring the world through our lens.
Latest news
Related news
- Advertisement -